Literature DB >> 9154813

Cytoplasmic p53 polypeptide is associated with ribosomes.

B M Fontoura1, C A Atienza, E A Sorokina, T Morimoto, R B Carroll.   

Abstract

Our previous finding that the tumor suppressor p53 is covalently linked to 5.8S rRNA suggested functional association of p53 polypeptide with ribosomes. p53 polypeptide is expressed at low basal levels in the cytoplasm of normal growing cells in the G1 phase of the cell cycle. We report here that cytoplasmic wild-type p53 polypeptide from both rat embryo fibroblasts and MCF7 cells and the A135V transforming mutant p53 polypeptide were found associated with ribosomes to various extents. Treatment of cytoplasmic extracts with RNase or puromycin in the presence of high salt, both of which are known to disrupt ribosomal function, dissociated p53 polypeptide from the ribosomes. In immunoprecipitates of p53 polypeptide-associated ribosomes, 5.8S rRNA was detectable only after proteinase K treatment, indicating all of the 5.8S rRNA in p53-associated ribosomes is covalently linked to protein. While 5.8S rRNA linked to protein was found in the immunoprecipitates of either wild-type or A135V mutant p53 polypeptide associated with ribosomes, little 5.8S rRNA was found in the immunoprecipitates of the slowly sedimenting p53 polypeptide, which was not associated with ribosomes. In contrast, 5.8S rRNA was liberated from bulk ribosomes by 1% sodium dodecyl sulfate, without digestion with proteinase K, indicating that these ribosomes contain 5.8S rRNA, which is not linked to protein. Immunoprecipitation of p53 polypeptide coprecipitated a small fraction of ribosomes. p53 mRNA immunoprecipitated with cytoplasmic p53 polypeptide, while GAPDH mRNA did not. These results show that cytoplasmic p53 polypeptide is associated with a subset of ribosomes, having covalently modified 5.8S rRNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154813      PMCID: PMC232167          DOI: 10.1128/MCB.17.6.3146

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization.

Authors:  H W Stürzbecher; R Brain; C Addison; K Rudge; M Remm; M Grimaldi; E Keenan; J R Jenkins
Journal:  Oncogene       Date:  1992-08       Impact factor: 9.867

2.  Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase.

Authors:  A E Koromilas; S Roy; G N Barber; M G Katze; N Sonenberg
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

3.  Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.

Authors:  D Lin; M T Shields; S J Ullrich; E Appella; W E Mercer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

4.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

Review 5.  Selective translation and degradation of heat-shock messenger RNAs in Drosophila.

Authors:  S Lindquist; R Petersen
Journal:  Enzyme       Date:  1990

6.  p53 is covalently linked to 5.8S rRNA.

Authors:  B M Fontoura; E A Sorokina; E David; R B Carroll
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

7.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  The translation machinery and 70 kd heat shock protein cooperate in protein synthesis.

Authors:  R J Nelson; T Ziegelhoffer; C Nicolet; M Werner-Washburne; E A Craig
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

9.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

Authors:  T G Graeber; J F Peterson; M Tsai; K Monica; A J Fornace; A J Giaccia
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

10.  Negative feedback regulation of wild-type p53 biosynthesis.

Authors:  J Mosner; T Mummenbrauer; C Bauer; G Sczakiel; F Grosse; W Deppert
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

View more
  20 in total

1.  Regulation of p53 localization and activity by Ubc13.

Authors:  Aaron Laine; Ivan Topisirovic; Dayong Zhai; John C Reed; Katherine L B Borden; Ze'ev Ronai
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

2.  Interdependence of Pes1, Bop1, and WDR12 controls nucleolar localization and assembly of the PeBoW complex required for maturation of the 60S ribosomal subunit.

Authors:  Michaela Rohrmoser; Michael Hölzel; Thomas Grimm; Anastassia Malamoussi; Thomas Harasim; Mathias Orban; Iris Pfisterer; Anita Gruber-Eber; Elisabeth Kremmer; Dirk Eick
Journal:  Mol Cell Biol       Date:  2007-03-12       Impact factor: 4.272

Review 3.  p53 RNA interactions: new clues in an old mystery.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

4.  Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain.

Authors:  Petar Stefanov Kovachev; Debapriya Banerjee; Luciana Pereira Rangel; Jonny Eriksson; Murilo M Pedrote; Mafalda Maria D C Martins-Dinis; Katarina Edwards; Yraima Cordeiro; Jerson L Silva; Suparna Sanyal
Journal:  J Biol Chem       Date:  2017-04-18       Impact factor: 5.157

5.  The DEAD-box RNA helicase DDX41 is a novel repressor of p21WAF1/CIP1 mRNA translation.

Authors:  Dominik Peters; Claudia Radine; Alina Reese; Wilfried Budach; Dennis Sohn; Reiner U Jänicke
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

6.  p53 is a general repressor of RNA polymerase III transcription.

Authors:  C A Cairns; R J White
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

7.  p53 regulates its own expression by an intrinsic exoribonuclease activity through AU-rich elements.

Authors:  Sanaz Derech-Haim; Yael Friedman; Amnon Hizi; Mary Bakhanashvili
Journal:  J Mol Med (Berl)       Date:  2020-02-04       Impact factor: 4.599

8.  mTORC1 and p53: clash of the gods?

Authors:  Paul Hasty; Zelton Dave Sharp; Tyler J Curiel; Judith Campisi
Journal:  Cell Cycle       Date:  2013-01-01       Impact factor: 4.534

Review 9.  Nucleolar control of p53: a cellular Achilles' heel and a target for cancer therapy.

Authors:  Nikolina Vlatković; Mark T Boyd; Carlos P Rubbi
Journal:  Cell Mol Life Sci       Date:  2013-05-18       Impact factor: 9.261

10.  The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer.

Authors:  Mustafa Akkiprik; Limei Hu; Aysegul Sahin; Xishan Hao; Wei Zhang
Journal:  BMC Cancer       Date:  2009-04-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.